Qualigen Therapeutics Inc (QLGN)

Qualigen Therapeutics Inc 주식(QLGN)의 최신 뉴스

Qualigen Therapeutics' Novel Direct Pan-RAS Inhibitors Presented at American Association of Cancer Research (AACR) 2024 Annual Meeting

GlobeNewswire Inc.

Qualigen Therapeutics Announces Poster Featuring Positive Early Clinical Experience with QN-302, a Novel First-in-Class G-Quadruplex Experimental Anti-Cancer Drug, at the American Association of Cancer Research (AACR) 2024 Annual Meeting

GlobeNewswire Inc.

Why Richardson Electronics Shares Are Trading Lower By 13%; Here Are 20 Stocks Moving Premarket

Benzinga

Qualigen Therapeutics Provides Corporate Update for Third Quarter and To Date 2023

GlobeNewswire Inc.